Drug Delivery Device Market

A drug delivery device is defined as the device used to deliver a therapeutic substance and enables a therapeutic substance to reach its site of action without reaching non-target cells, organs, and/or tissues. These devices are used as part of one or more medical treatments to delivery a drug or a therapeutic agent via a specific route of administration.

Market Dynamics:

Increasing burden of chronic/non-communicable diseases, increasing adoption of technologically advanced drug delivery devices, rapid growth in the biologics market, and the outbreak of COVID-19 are major factors expected to drive growth of the global drug delivery device market.

For instance, in September 2022, Corium, Inc. announced that ADLARITY (donepezil transdermal system) is now available for prescription in the United States for the treatment of people with mild, moderate, or severe dementia of Alzheimer's type. Moreover, in February 2022, Takeda received the U.S. Food and Drug Administration (USFDA) approval for TAKHZYRO (lanadelumab-flyo) injection single-dose prefilled syringe, which is used to prevent attacks of hereditary angioedema (HAE) in adult and pediatric patients 12 years of age and older.

Key features of the study:

• This report provides in-depth analysis of the global drug delivery device market, and provides market size (US$ Million) and compound annual growth rate (CAGR %) for the forecast period (2022–2028), considering 2021 as the base year.
• It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
• This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
• It profiles key players in the global drug delivery device market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
• Key companies covered as a part of this study include Pfizer Inc., Novartis AG (Sandoz), F. Hoffmann-La Roche Ltd., Johnson & Johnson, and Bayer AG, among others.
• Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
• The global drug delivery device market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
• Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global drug delivery device market.

Detailed Segmentation:

• Global Drug Delivery Device Market, By Route of Administration:
  • Injectable
  • Topical
  • Ocular
  • Other Routes of Administration
• Global Drug Delivery Device Market, By Application:
  • Cancer
  • Cardiovascular
  • Diabetes
  • Infectious Diseases
  • Other Applications
• Global Drug Delivery Device Market, By End User:
  • Hospitals
  • Ambulatory Surgical Centers
  • Other End Users
• Global Drug Delivery Device Market, By Geography:
  • North America
  • Europe
  • Asia-Pacific
  • Middle East and Africa
  • South America
• Company Profiles:
  • Pfizer Inc.
  • Novartis AG (Sandoz)
  • F. Hoffmann-La Roche Ltd.
  • Johnson & Johnson
  • Bayer AG